Browsing Tag
Aducanumab
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
Elana Gotkine
TUESDAY, Dec. 6, 2022 (HealthDay News) -- The U.S. Food and Drug…
Read More...
Read More...
Medicare Finalizes Limits on Aducanumab Coverage
In its final decision about…
Read More...
Read More...
Aducanumab Data Finally Published, but Alzheimer’s Experts Spot Problems
The long-awaited results of…
Read More...
Read More...
National Down Syndrome Organizations Launch Joint Effort To Change CMS Proposal Concerning Coverage…
Atlanta, GA., Bismarck, ND., Burlington, MA., Denver, CO., Hoffman Estates, IL, NY, NY, Rockport, ME, Feb. 04, 2022…
Read More...
Read More...
Brain Inflammation Seen in Four of 10 Alzheimer’s Aducanumab Patients
Brain inflammation known…
Read More...
Read More...
Let Ethics Guide Aducanumab Prescribing, AAN Says
With incomplete data to…
Read More...
Read More...
One Aducanumab Patient, Six Brain Edema Episodes
A man treated with the…
Read More...
Read More...
FDA to OK Boosters for Some; VA Passes on Aducanumab; Bogus COVID Vakzine
Note that some links may…
Read More...
Read More...
Aducanumab Glass Half Empty. No, It’s Half Full
Three opinion pieces…
Read More...
Read More...